Tikum AF, Fon DA, Njotu FN, Henning N, et al. [(225)Ac]Ac-labeled matuzumab is an effective radioimmunotherapeutic against EGFR-positive triple negative breast cancer. Breast Cancer Res 2026 Jan 16. doi: 10.1186/s13058-026-02220.
PMID: 41546059